| Date | Form | Description | Docs | XBRL | Pages |
| 04/16/14 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
41 | |
| 04/15/14 | UPLOAD | SEC-generated letter |
|
1 | |
| 04/09/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
5 | |
| 04/07/14 | UPLOAD | SEC-generated letter |
|
2 | |
| 03/31/14 | S-3/A | Registration statement for specified transactions by certain issuers |
|
101 | |
| 03/31/14 | 8-K | Current report filing |
|
4 | |
| 03/28/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 03/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/17/14 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
74 |
Latest News & Events
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Read More...Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
Read More...Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Read More...